Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment”
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | JHEP Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555924002842 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1825206865253892096 |
---|---|
author | Philippa C. Matthews Tingyan Wang Eleanor Barnes |
author_facet | Philippa C. Matthews Tingyan Wang Eleanor Barnes |
author_sort | Philippa C. Matthews |
collection | DOAJ |
format | Article |
id | doaj-art-4c6683f4c5d44098a1df97c211bd2401 |
institution | Kabale University |
issn | 2589-5559 |
language | English |
publishDate | 2025-02-01 |
publisher | Elsevier |
record_format | Article |
series | JHEP Reports |
spelling | doaj-art-4c6683f4c5d44098a1df97c211bd24012025-02-07T04:48:09ZengElsevierJHEP Reports2589-55592025-02-0172101280Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment”Philippa C. Matthews0Tingyan Wang1Eleanor Barnes2The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Division of Infection and Immunity, University College London, Gower Street, London, WC1E 6BT, UK; Department of Infectious Diseases, University College London Hospital, Euston Road, London NW1 2BU, UK; Mortimer Market Centre, Central North West London NHS Trust, Capper Street, London WC1E 6JB, UK; Corresponding author. Address: The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.NIHR Oxford Biomedical Research Centre, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UKNIHR Health Informatics Collaborative, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Department of Hepatology, Oxford University Hospitals NHS Foundation Trust, Oxford, UKhttp://www.sciencedirect.com/science/article/pii/S2589555924002842 |
spellingShingle | Philippa C. Matthews Tingyan Wang Eleanor Barnes Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment” JHEP Reports |
title | Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment” |
title_full | Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment” |
title_fullStr | Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment” |
title_full_unstemmed | Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment” |
title_short | Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment” |
title_sort | reply to understanding virologic heterogeneity in chronic hepatitis b treatment |
url | http://www.sciencedirect.com/science/article/pii/S2589555924002842 |
work_keys_str_mv | AT philippacmatthews replytounderstandingvirologicheterogeneityinchronichepatitisbtreatment AT tingyanwang replytounderstandingvirologicheterogeneityinchronichepatitisbtreatment AT eleanorbarnes replytounderstandingvirologicheterogeneityinchronichepatitisbtreatment |